References
Key articles
Karbowiak M, Holme T, Khan K, et al. Dupuytren's disease. BMJ. 2021 Jun 4;373:n1308. Abstract
Boe C, Blazar P, Iannuzzi N. Dupuytren contractures: an update of recent literature. J Hand Surg Am. 2021 Oct;46(10):896-906.Full text Abstract
Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000 Nov;25(6):1157-62. Abstract
Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007 Jul-Aug;32(6):767-74. Abstract
Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009 Sep 3;361(10):968-79.Full text Abstract
Reference articles
1. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005 Nov;68(5):424-9. Abstract
2. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J. 2005 Jul;81(957):425-8.Full text Abstract
3. Tubiana R. Evaluation of deformities in Dupuytren's disease. Ann Chir Main. 1986;5:5-11. Abstract
4. Salari N, Heydari M, Hassanabadi M, et al. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2020 Oct 28;15(1):495.Full text Abstract
5. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin. 1999;15:53-62. Abstract
6. Lanting R, Broekstra DC, Werker PMN, et al. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast Reconstr Surg. 2014 Mar;133(3):593-603. Abstract
7. Lanting R, van den Heuvel ER, Westerink B, et al. Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg. 2013 Aug;132(2):394-403. Abstract
8. Nordenskjöld J, Englund M, Zhou C, et al. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study. J Hand Surg Eur Vol. 2017 Sep;42(7):673-7. Abstract
9. Broekstra DC, Kuo RYL, Burn E, et al. Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis. Plast Reconstr Surg. 2023 Mar 1;151(3):581-91.Full text Abstract
10. Tajika T, Kobayashi T, Kaneko T, et al. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan. J Orthop Sci. 2014 Jan;19(1):64-70.Full text Abstract
11. Lee LC, Zhang AY, Chong AK, et al. Expression of a novel gene, MafB, in Dupuytren's disease. J Hand Surg Am. 2006 Feb;31(2):211-8. Abstract
12. Bayat A, Walter J, Lambe H, et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg. 2005 Jan;115(1):134-41. Abstract
13. Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br. 2003 May;85(4):469-77.Full text Abstract
14. Chammas M, Bousquet P, Renard E, et al. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995 Jan;20(1):109-14. Abstract
15. Geoghegan JM, Forbes J, Clark DI, et al. Dupuytren's disease risk factors. J Hand Surg Br. 2004 Oct;29(5):423-6. Abstract
16. Rydberg M, Zimmerman M, Löfgren JP, et al. Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years. Sci Rep. 2021 Jul 19;11(1):14669.Full text Abstract
17. Godtfredsen NS, Lucht H, Prescott E, et al. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol. 2004 Aug;57(8):858-63. Abstract
18. Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital - a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007;8:60.Full text Abstract
19. Karbowiak M, Holme T, Khan K, et al. Dupuytren's disease. BMJ. 2021 Jun 4;373:n1308. Abstract
20. Arafa M, Noble J, Royle SG, et al. Dupuytren's and epilepsy revisited. J Hand Surg Br. 1992 Apr;17(2):221-4. Abstract
21. Bisson MA, McGrouther DA, Mudera V, et al. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg Br. 2003 Aug;28(4):351-6. Abstract
22. Boe C, Blazar P, Iannuzzi N. Dupuytren contractures: an update of recent literature. J Hand Surg Am. 2021 Oct;46(10):896-906.Full text Abstract
23. Freehafer AA, Strong JM. The treatment of Dupuytren's contracture by partial fasciectomy. J Bone Joint Surg Am. 1963;45:1207-16. Abstract
24. Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14:131.Full text Abstract
25. Rodrigues JN, Becker GW, Ball C, et al. Surgery for Dupuytren's contracture of the fingers. Cochrane Database Syst Rev. 2015;(12):CD010143.Full text Abstract
26. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease--a systematic review. J Hand Surg Eur Vol. 2010 Oct;35(8):623-6. Abstract
27. Harvey LA, Katalinic OM, Herbert RD, et al. Stretch for the treatment and prevention of contractures. Cochrane Database Syst Rev. 2017;(1):CD007455.Full text Abstract
28. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000 Nov;25(6):1157-62. Abstract
29. Lipman MD, Carstensen SE, Deal DN. Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014. Hand (N Y). 2017 Jan;12(1):13-20.Full text Abstract
30. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007 Jul-Aug;32(6):767-74. Abstract
31. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009 Sep 3;361(10):968-79.Full text Abstract
32. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010 Apr;35(4):534-9. Abstract
33. Kemler MA, de Wijn RS, van Rijssen AL, et al. Dutch multidisciplinary guideline on Dupuytren disease. J Hand Surg Glob Online. 2023 Mar;5(2):178-83.Full text Abstract
34. Bainbridge C, Gerber RA, Szczypa PP, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg. 2012 Sep;46(3-4):177-83.Full text Abstract
35. Toppi JT, Trompf L, Smoll NR, et al. Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy. ANZ J Surg. 2015 Sep;85(9):639-43. Abstract
36. Zhou C, Selles RW, Slijper HP, et al. Comparative effectiveness of percutaneous needle aponeurotomy and limited fasciectomy for Dupuytren's contracture: a multicenter observational study. Plast Reconstr Surg. 2016 Oct;138(4):837-46. Abstract
37. van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006 May-Jun;31(5):717-25. Abstract
38. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003 Oct;28(5):427-31. Abstract
39. Soreide E, Murad MH, Denbeigh JM, et al. Treatment of Dupuytren's contracture: a systematic review. Bone Joint J. 2018 Sep;100-B(9):1138-45. Abstract
40. Chen NC, Srinivasan RC, Shauver MJ, et al. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y). 2011 Sep;6(3):250-5.Full text Abstract
41. Strömberg J, Ibsen-Sörensen A, Fridén J. Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up. J Hand Surg Am. 2016 Sep;41(9):873-80. Abstract
42. Skov ST, Bisgaard T, Søndergaard P, et al. Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial. J Hand Surg Am. 2017 May:42(5):321-8. Abstract
43. Rowley DI, Couch M, Chesney RB, et al. Assessment of percutaneous fasciotomy in the management of Dupuytren's contracture. J Hand Surg Br. 1984 Jun;9(2):163-4. Abstract
44. Colville J. Dupuytren's contracture - the role of fasciotomy. Hand. 1983 Jun;15(2):162-6. Abstract
45. Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren's contracture. J Hand Surg Br. 1988 Aug;13(3):254-6. Abstract
46. Rayan GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007 Jan;89(1):189-98. Abstract
47. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg Br. 1996;21:797-800. Abstract
48. Moermans JP. Segmental aponeurectomy in Dupuytren's disease. J Hand Surg Br. 1991 Aug;16(3):243-54. Abstract
49. Townley WA, Baker R, Sheppard N, et al. Dupuytren's contracture unfolded. BMJ. 2006;332:397-400.Full text Abstract
50. Au-Yong IT, Wildin CJ, Dias JJ, et al. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg. 2005 Dec;9(4):178-87. Abstract
51. Umlas ME, Bischoff RJ, Gelberman RH. Predictors of neurovascular displacement in hands with Dupuytren's contracture. J Hand Surg Br. 1994 Oct;19(5):664-6. Abstract
52. McCash CR. The open palm technique in Dupuytren's contracture. Br J Plast Surg. 1964;17:271-80 Abstract
53. Kemler MA, Houpt P, van der Horst CM. A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy for Dupuytren's disease. J Hand Surg Eur Vol. 2012 Oct;37(8):733-7. Abstract
54. Collis J, Collocott S, Hing W, et al. The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-center, randomized, controlled trial. J Hand Surg Am. 2013 Jul;38(7):1285-94. Abstract
55. McIndoe A, Beare RL. The surgical management of Dupuytren's contracture. Am J Surg. 1958;95:197-203. Abstract
56. Zachariae L. Extensive versus limited fasciectomy for Dupuytren's contracture. Scand J Plast Reconstr Surg. 1967;1(2):150-3. Abstract
57. Abe Y, Rokkaku T, Kuniyoshi K, et al. Clinical results of dermofasciectomy for Dupuytren's disease in Japanese patients. J Hand Surg Eur Vol. 2007 Aug;32(4):407-10. Abstract
58. Searle AE, Logan AM. A mid-term review of the results of dermofasciectomy for Dupuytren's disease. Ann Chir Main Memb Super. 1992;11(5):375-80. Abstract
59. Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren's contracture. J Hand Surg Am. 1987 Sep;12:659-64. Abstract
60. Kelly C, Varian J. Dermofasciectomy: a long term review. Ann Chir Main Memb Super. 1992;11(5):381-2. Abstract
61. Weinzierl G, Flügel M, Geldmacher J. Lack of effectiveness of alternative non-surgical treatment procedures of Dupuytren contracture. Chirurg. 1993 Jun;64(6):492-4. Abstract
62. Sakellariou VI, Brault J, Rizzo M. Ultrasound-assisted percutaneous needle fasciotomy for Dupuytren's contracture. Orthopedics. 2015 May;38(5):299-303. Abstract
63. Nanchahal J, Ball C, Rombach I, et al. Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2022 Jun;4(6):E407-16.Full text Abstract
64. Gudmundsson KG, Arngrimsson R, Jónsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scand J Rheumatol. 2001;30(1):31-4. Abstract
65. Boyer MI, Gelberman RH. Complications of the operative treatment of Dupuytren's disease. Hand Clin. 1999 Feb;15(1):161-6. Abstract
Use of this content is subject to our disclaimer